Rheumatology International

, Volume 26, Issue 1, pp 80–82 | Cite as

Diabetes insipidus presentation before renal and pulmonary features in a patient with Wegener’s granulomatosis

  • Nurşen Düzgün
  • Yonca Morris
  • Sevim Güllü
  • Alptekin Gürsoy
  • Arzu Ensari
  • Özlem Özdemir Kumbasar
  • Murat Duman
Case Report

Abstract

We report a case of a 47-year-old woman with Wegener’s granulomatosis complicated by central diabetes insipidus. The patient had initially seronegative polyarthritis which mostly responded well to methotrexate and steroid therapy. Eight months later the patient suffered from polyuria and polydipsia. There were no abnormalities of the anterior pituitary hormones. MR images showed only loss of brightness of the posterior pituitary. Extensive evaluation of the patient revealed the presence of ANCA, in c-ANCA pattern and also PR3 positivity. Three months later findings of glomerulonephritis, as suggested by an active urine sediment and gradual proteinuria, and, finally, asymptomatic pulmonary nodules completed the clinical picture of Wegener’s disease within 1 year. Renal biopsy showed crescent formation in two glomeruli, consistent with ANCA-related glomerulonephritis which showed pauci-immün depositions by direct immunofluorescence. Diabetes insipidus symptoms mostly regressed; renal and pulmonary findings completely disappeared with glucocorticoid and pulse cyclophosphamide treatment. These findings show that diabetes insipidus may rarely develop early in the disease process and ANCA positivity was directly indicative of Wegener’s granulomatosis before the classic clinical signs of the disease.

Keywords

Arthritis Diabetes insipidus  Wegener granulomatosis ANCA 

References

  1. 1.
    Jenette JC, Falk RJ, Andrassy K, Bacon PA et al (1994) Nomenclature of syndrome vasculitides: the proposal of an international consensus conference. Arthritis Rheum 37:187–192Google Scholar
  2. 2.
    Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW et al (1992) Wegener’s granulomatosis; an analysis of 158 patients. Ann Intern Med 116:488–498Google Scholar
  3. 3.
    Hurst NP, Dunn NA, Chalmers TM (1983) Wegener’s granulomatosis complicated by diabetes insipidus. Ann Rheum Dis 42:600–660Google Scholar
  4. 4.
    Nishino H, Rubino F, DeRemee RA, Swanson JW et al (1993) Neurological involvement in Wegener granulomatosis: analysis of 324 consecutive patients at Mayo Clinic. Ann Neurol 33:4–9Google Scholar
  5. 5.
    Rosete A, Cabral AR, Kraus A, Alarcon-Segovia D (1991) Diabetes insipidus secondary to Wegener’s granulomatosis: report and review of the literature. J Rheumatol 18:761–765Google Scholar
  6. 6.
    Garovic VD, Clark BL, Chilson TS, Specks U (2001) Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener’s granulomatosis. Am J Kidney Dis 37(1):E5Google Scholar
  7. 7.
    Berthier S, Gil H, Bonneville JF, Magy N, De Wazieres B, Mallet H, Dupond JL (2000) Wegener’s disease and central diabetes insipidus. Ann Endocrinol (Paris) 61:531–537Google Scholar
  8. 8.
    Roberts GA, Erin A, Sinclair H, Pelling M et al (1995) Two cases of Wegener’s granulomatosis involving the pituitary. Clin Endocrinol 42:325–328Google Scholar
  9. 9.
    Katzman GL, Langford CA, Sneller MC, Koby M, Patronas NJ (1999) Pituitary involvement by Wegener’s granulomatosis: a report of two cases. Am J Neuroradiol 20:519–570Google Scholar
  10. 10.
    Czarnecki EJ, Spickler EM (1995) Magnetic resonance demonstration of Wegener granulomatosis of the infindibulum, a case of diabetes insipidus. AJNR Am J Neuroradiol 16(4 Supp I):968–70Google Scholar
  11. 11.
    Goebel R, Jakse R, Passath A, Michalmayr G (1982) Wegener granulomatosis causing diabetes insipidus. Fortschr Med 100:1400–1402Google Scholar
  12. 12.
    Haynes BF, Fauci AS (1978) Diabetes Insipidus associated with Wegener’s granulomatosis successfully treated with cyclophosphamide. N Engl J Med 299:764Google Scholar
  13. 13.
    Miesen WMAJ, Janssens ENW, van Bommel EFH (1999) Diabetes insipidus as the presenting symptom of Wegener’s granulomatosis. Nephrol Dial Transplant 14:426–429Google Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Nurşen Düzgün
    • 1
  • Yonca Morris
    • 1
  • Sevim Güllü
    • 2
  • Alptekin Gürsoy
    • 2
  • Arzu Ensari
    • 3
  • Özlem Özdemir Kumbasar
    • 4
  • Murat Duman
    • 1
  1. 1.Department of Clinical Immunology and RheumatologyAnkara University School of MedicineAnkaraTurkey
  2. 2.Department of Endocrinology and Metabolic DiseasesAnkara University School of MedicineAnkaraTurkey
  3. 3.Department of PathologyAnkara University School of MedicineAnkaraTurkey
  4. 4.Department of Chest DiseasesAnkara University School of MedicineAnkaraTurkey

Personalised recommendations